PT Ikapharmindo Putramas Tbk (IDX:IKPM)
Indonesia · Delayed Price · Currency is IDR 202.00
-4.00 (-1.94%)
At close: Apr 28, 2026
IDX:IKPM Revenue
In the year 2025, PT Ikapharmindo Putramas Tbk had annual revenue of 363.57B IDR, down -11.77%. PT Ikapharmindo Putramas Tbk had revenue of 106.47B in the quarter ending December 31, 2025, a decrease of -12.86%.
Revenue
363.57B
Revenue Growth
-11.77%
P/S Ratio
0.90
Revenue / Employee
371.90M
Employees
1,014
Market Cap
340.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 363.57B | -48.50B | -11.77% |
| Dec 31, 2024 | 412.07B | -29.07B | -6.59% |
| Dec 31, 2023 | 441.14B | 42.40B | 10.63% |
| Dec 31, 2022 | 398.73B | 17.82B | 4.68% |
| Dec 31, 2021 | 380.92B | -334.88B | -46.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 35.32T |
| PT Siloam International Hospitals Tbk | 12.85T |
| PT Mitra Keluarga Karyasehat Tbk | 5.37T |
| PT Millennium Pharmacon International Tbk | 4.11T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.59T |
| PT Phapros Tbk | 961.30B |
| PT Royal Prima Tbk | 338.91B |
| PT Indofarma Tbk | 206.24B |